CompletedPHASE1, PHASE2NCT03617718

Project 2 Airway Potential Hydrogen (pH) in Asthma

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Case Western Reserve University
Principal Investigator
Kristie R Ross, MD
University Hospitals Cleveland Medical Center
Intervention
Glycine Buffer(drug)
Enrollment
74 enrolled
Eligibility
18-50 years · All sexes
Timeline
20182025

Study locations (2)

Collaborators

National Institutes of Health (NIH) · National Heart, Lung, and Blood Institute (NHLBI) · University Hospitals Cleveland Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03617718 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis

← Back to all trials